New Investments
South African Biotech Startup Immobazyme Secures $1.3 Million in Funding
The funding was led by the The University Technology Fund (UTF) and University of Stellenbosch Enterprises.
Immobazyme leverages precision fermentation technology to develop high-value protein ingredients.
Their product range includes growth factors for the burgeoning cell-cultured meat industry, enzymes like dextranase for the sugar industry, and food ingredients for the food and beverage sector.
With this funding boost, Immobazyme plans to double the size of its production facility and expand its capacity.
This investment highlights the growing interest in alternative protein sources and the potential of precision fermentation technology.
Immobazyme’s expansion plans position them to play a significant role in these developing markets.
Related Articles
Register Now
Empower Africa Times Newsletter
Share :
“We are delighted to partner with ISA to support the development of solar energy in Africa,” said Alain Ebobissé, CEO of Africa50. “This partnership will help to accelerate the deployment of solar energy in Africa and improve the lives of millions of Africans,” he added.
You may also like...
South African Fintech Startup LittleFish Secures Seed Funding Led by TLcom Capital to Empower SMEs
South African fintech startup LittleFish has successfully closed its seed investment round, with TLcom Capital leading the financing and Flourish Ventures participating as a co-investor.
Maisha Meds Receives $5 Million in Funding From USAID to Expand Access to Affordable Malaria Care in Africa
Maisha Meds, a leading digital health organization in Africa, has received US$5.25 million in scale-up stage 3 funding from the United States Agency for International Development (USAID) Development Innovation Ventures (DIV).
Norfund Commits $20 Million to Boost Fintech Growth in Emerging Markets
Norfund, a Norwegian investment management company focused on developing markets, announced a $20 million commitment to the Apis Growth Markets Fund III.